Mouth Ulcers Drugs Market to Cross USD 1.5 Billion by 2020

Mouth Ulcers Drugs Market – Global Indications, Drug Classes and Formulations Analysis and Forecast 2013-2020, estimates the global mouth ulcers drugs market to reach nearly USD 1.5 Billion in 2020, at a CAGR of 2.9% from 2016 to 2020 - iHealthcareAnalyst, Inc.

Visit the Mouth Ulcers Drugs Market – Global Indications, Drug Classes and Formulations Analysis and Forecast 2013-2020 report http://www.ihealthcareanalyst.com/report/mouth-ulcers-treatment-market/

Mouth ulcers treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as dry mouth or substituting a problem medication. Maintaining good oral hygiene and use of an antiseptic mouthwash or spray (e.g. chlorhexidine) can prevent secondary infection and therefore hasten healing. A topical analgesic (e.g. benzydamine mouthwash) may reduce pain. Topical (gels, creams or inhalers) or systemic steroids may be used to reduce inflammation. An antifungal drug may be used to prevent oral candidiasis developing in those who use prolonged steroids. The global mouth ulcers drugs market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the indications (aphthous stomatitis, oral lichen planus, etc.), drug classes (analgesic, anesthetic, antihistamine, antimicrobial, and Corticosteroids), formulation type (gel, lozenge, mouthwash, and sprays), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends.

The global mouth ulcers drugs market is segmented as:

1. Indication
1.1. Aphthous Stomatitis
1.2. Oral Lichen Planus
1.3. Others

2. Drug Class
2.1. Analgesic
2.2. Anesthetic
2.3. Antihistamine
2.4. Antimicrobial
2.5. Corticosteroid

3. Formulation
3.1. Gel
3.2. Lozenge
3.3. Mouthwash
3.4. Spray

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. 3M
5.2. BLISTEX, INC.
5.3. Bristol-Myers Squibb Company
5.4. Church & Dwight Co., Inc.
5.5. ECR Pharmaceuticals
5.6. GlaxoSmithKline plc.
5.7. Pfizer, Inc.
5.8. Taro Pharmaceutical Industries Ltd.
5.9. The Colgate-Palmolive Company

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.